Abbott’s management not pleased with Act Up-Paris article …
The Abbott pharmaceutical company is withdrawing a 4000 euros subsidy it granted to Act Up-Paris - a subsidy intended to sponsor our activity at the international aids conference in Toronto. For what reason? Because of a recent article published in our journal Protocoles - which provides information about new HIV treatments and research - on a new formula of Norvir, an anti-HIV treatment.